Kraig Biocraft Laboratories, Inc.
KBLB· OTC
Filed May 15, 2025 · 10-Q · 45 days after period end · 0001641172-25-010985
| Metric | Q1 2025 | Q1 2024 | Q1 2023 | Q1 2022 |
|---|---|---|---|---|
| Net Income | -$600.03K | -$507.88K | -$566.78K | -$1.05M |
| EPS Diluted | $0.00 | $0.00 | $0.00 | — |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Kraig Biocraft Laboratories, Inc. · CIK 1413119 · Engraved from SEC EDGAR
ended Mar 31, 2025 · filed May 15, 2025 · 45 d after period end